CFO.com reports that Bristol-Myers Restates Last Five Years. Drug maker Bristol-Myers Squibb Co. announced that it revised its fourth-quarter 2003 earnings upward, from $429 million to $506 million, and raised revenues, from $5.6 billion to $5.7 billion, to correct accounting errors.